Omnicell Builds Out its Medication Synchronization Platform
People with chronic medical conditions typically take a lot of medications, and it’s not uncommon that many of them skip or forget to take some of their meds as prescribed. A 2011 survey released by the National Consumers League projected that the number of Americans affected by at least one chronic condition requiring medication therapy is expected to reach 157 million by 2020. Into the breach comes Omnicell, Inc. (NASDAQ: OMCL), which provides automation and business analytics software solutions for medication and supply management worldwide. The company announced its acquisition of privately held Ateb, Inc. and its affiliate, Ateb Canada Ltd. on November 29. The... Read More »The Market for PBMs Slows in 2016
Magellan Health, Inc. (NASDAQ: MGLN), a healthcare management company specializing in special populations and pharmacy benefits management, has just acquired privately held Veridicus Holdings, LLC. The sellers are Gauge Capital, company management and other unnamed backers. Based in Salt Lake City, Veridicus is a pharmacy benefit management (PBM) company that uses proprietary software to integrate pharmacy, medical and lab data to drive targeted interventions for complex patient populations. The $74.5 million deal gives Magellan access to Veridicus’ 225,000 members. Veridicus also owns and operates a fully licensed insurance company which serves members enrolled in the Medicare Part D... Read More »CROs Are Back, Many with Specialties
We’ve documented the increase in biotechnology acquisitions and license deals by pharmaceutical companies in previous posts. But the impact of pharma’s move away from in-house R&D has benefited other sectors of the healthcare industry, particularly clinical research organizations (CROs). For those outside the technology side of healthcare, CROs provide outsourced research services to the pharmaceutical, biotechnology, and medical device industries on a contract basis. Through mid-November, we’ve seen an increase of 325% in deal volume for CROs, compared with the year before. In 2015, just five deals for these targets were announced. So far this year, 17 are on the... Read More »What U.S. Hospitals Are Acquiring in 2016
Hospital acquisitions have surged since the Affordable Care Act was passed in 2010. That year, 76 deals were announced, with a U.S. hospital or health system as a target. By 2012, 107 transactions were recorded for hospital targets, and that still stands as the highest number of deals per year. Only 2015 came close, with 102 hospital transactions. Through mid-November, there have been 79 deals announced with U.S. hospitals or health systems as the target. But what are U.S. hospitals acquiring for their own financial health? Other hospitals or health systems make up the majority of targets every year, of course. So far this year, through mid November, 66 transactions... Read More »October M and A Settles into Second Place
What’s a synonym for “slowdown?” We’re as tired of writing about monthly deal volume dropping off as you probably are of reading about it. But M&A activity in October 2016 can only be summed up as slackening, declining, decelerating. Preliminary deal volume is now at the second-lowest level of the year, just 112 transactions. Only January’s deal volume was lower, at 104 transactions. We may have a few additions to October’s total as the fourth quarter grinds on, but it’s not typical to find another 15 deals. Deal value also dropped off. At $12.8 billion, it ranks as the second-lowest level of spending for the year. July 2016 still holds the honor of being the slowest month for... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
